- The Washington Times - Thursday, October 2, 2003

SAN FRANCISCO (AP) — The lofty goal of “personalized medicine” came one step closer to reality yesterday when two companies announced success in placing vital bits of humankind’s estimated 35,000 genes on a small glass chip.

Rivals Affymetrix Inc. and Agilent Technologies produced “gene chips” — dime-size pieces of glass infused with genetic material. Until yesterday, Affymetrix and Agilent needed two chips to hold the same genetic material.

Chips with portions of the genome are now indispensable in biology laboratories around the world. Now, Affymetrix says, researchers can buy the entire genome for between $300 and $500 each — roughly half the old price.

“It’s a significant milestone,” said Affymetrix Chief Executive Officer Stephen Fodor.

Employing semiconductor-manufacturing technology, workers “print” genes one molecule at a time onto the glass until they stand up like microscopic skyscrapers, each about 25 molecules high.

Researchers then drop onto the chips specially tagged RNA, which serves as the messenger between DNA blueprints and a cell’s protein-making machinery. The portion of a chip on which genes interact with the RNA will be fluorescent, highlighting bad genes that may need a closer look.

The rival announcements yesterday come on the heels of similar breakthroughs by Applied Biosystems of Foster City and Madison, Wis.-based NimbleGen Systems, both of which said in July they had each created a genome on a chip. In addition, a research team from two German science institutes made a similar announcement last year.

Because Affymetrix owns 80 percent of the commercial market, however, its announcement was greeted as an industry turning point.

The continued packing of more genes into smaller spaces leads many to believe the gene chip industry will follow its own Moore’s Law, which holds that the processing power of semiconductor chip doubles every 18 months.

While no one believes gene chips will evolve that quickly, many still expect big things.

Even the chips touted yesterday don’t contain whole genes on them. Instead, they contain vital pieces of each gene. But more genetic detail is expected to be added to the chips in coming years, making them more powerful and versatile.

Today, researchers mostly use the chips to do basic genetic research.

Scientists believe many diseases are caused by genes “turning on” when they shouldn’t. Knowing this, researchers can design drugs to attack suspect genes.

Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide